Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

ACAD

Acadia Pharmaceuticals Inc.

Healthcare · USD

Set alert

Price alert · ACAD

All alert types
20.59 USD -0.17 -0.82%
As of Oct 30, 2026 Extended hours 20.59 0.00%
Bid
20.59 × 1
Ask
20.61 × 1
20.49 Day range 21.01
18.62 52-week range 30.57
YTD
-22.91%
1 year
-9.45%
Open
20.88
Prev close
20.76
Mkt cap
3.53B
Vol
1.14M
Avg vol
1.88M
EPS
2.23
P/E
9.23
Div yield
0.00%
More statistics
Low
20.49
High
21.01
Forward P/E
22.43
Beta
0.89
Short ratio
3.81
Inst. own
100.04%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
23.91
200-d avg
23.71
1y target
30.53

5D chart

Chart tools
Interval
1m5m15m30m
ACAD five-day price chart19.519.920.320.621.0Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

4.90 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A-4 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 4
  • P/E 3
  • P/B 2

Valuation

P/E 11.5×
FY 2016: -12.3×FY 2017: -12.8×FY 2018: -8.3×FY 2019: -26.7×FY 2020: -29.9×FY 2021: -22.2×FY 2022: -11.9×FY 2023: -84.6×FY 2024: 13.4×FY 2025: 11.5×
FY 2016 5y median -11.9× FY 2025
P/S 4.2×
FY 2016: 193×FY 2017: 29.6×FY 2018: 9.1×FY 2019: 18.6×FY 2020: 19.0×FY 2021: 7.7×FY 2022: 5.0×FY 2023: 7.1×FY 2024: 3.2×FY 2025: 4.2×
FY 2016 5y median 5.0× FY 2025
P/B 3.7×
FY 2016: 6.4×FY 2017: 11.0×FY 2018: 4.3×FY 2019: 9.0×FY 2020: 13.4×FY 2021: 6.9×FY 2022: 6.4×FY 2023: 11.9×FY 2024: 4.1×FY 2025: 3.7×
FY 2016 5y median 6.4× FY 2025
P/FCF 43.0×
FY 2016: -15.2×FY 2017: -16.9×FY 2018: -12.1×FY 2019: -41.4×FY 2020: -58.5×FY 2021: -29.5×FY 2022: -22.6×FY 2023: -220×FY 2024: 19.3×FY 2025: 43.0×
FY 2016 5y median -22.6× FY 2025
EV/EBITDA 29.2×
FY 2016: -11.7×FY 2017: -12.5×FY 2018: -7.8×FY 2019: -25.1×FY 2020: -28.7×FY 2021: -22.3×FY 2022: -11.9×FY 2023: -110×FY 2024: 27.7×FY 2025: 29.2×
FY 2016 5y median -11.9× FY 2025
EV/Sales 4.1×
FY 2016: 183×FY 2017: 29.0×FY 2018: 8.5×FY 2019: 18.0×FY 2020: 18.4×FY 2021: 7.6×FY 2022: 4.9×FY 2023: 6.9×FY 2024: 2.9×FY 2025: 4.1×
FY 2016 5y median 4.9× FY 2025
FCF Yield 2.3%
FY 2016: -6.6%FY 2017: -5.9%FY 2018: -8.3%FY 2019: -2.4%FY 2020: -1.7%FY 2021: -3.4%FY 2022: -4.4%FY 2023: -0.5%FY 2024: 5.2%FY 2025: 2.3%
FY 2016 5y median -0.5% FY 2025

Profitability

Gross Margin 91.7%
FY 2016: 74.6%FY 2017: 89.5%FY 2018: 91.8%FY 2019: 94.2%FY 2020: 95.3%FY 2021: 96.0%FY 2022: 98.0%FY 2023: 93.7%FY 2024: 91.5%FY 2025: 91.7%
FY 2016 5y median 93.7% FY 2025
Operating Margin 9.8%
FY 2016: -1574.1%FY 2017: -234.1%FY 2018: -110.6%FY 2019: -72.7%FY 2020: -64.9%FY 2021: -35.2%FY 2022: -43.2%FY 2023: -10.1%FY 2024: 24.1%FY 2025: 9.8%
FY 2016 5y median -10.1% FY 2025
Net Margin 36.5%
FY 2016: -1565.9%FY 2017: -231.7%FY 2018: -109.6%FY 2019: -69.4%FY 2020: -63.7%FY 2021: -34.7%FY 2022: -41.8%FY 2023: -8.4%FY 2024: 23.6%FY 2025: 36.5%
FY 2016 5y median -8.4% FY 2025
ROE 31.9%
FY 2016: -52.4%FY 2017: -86.3%FY 2018: -51.2%FY 2019: -33.7%FY 2020: -44.9%FY 2021: -31.0%FY 2022: -53.9%FY 2023: -14.2%FY 2024: 30.9%FY 2025: 31.9%
FY 2016 5y median -14.2% FY 2025
ROIC 8.1%
FY 2016: -52.6%FY 2017: -87.2%FY 2018: -51.5%FY 2019: -34.6%FY 2020: -42.0%FY 2021: -27.8%FY 2022: -47.4%FY 2023: -14.6%FY 2024: 25.2%FY 2025: 8.1%
FY 2016 5y median -14.6% FY 2025
ROA 25.0%
FY 2016: -48.4%FY 2017: -75.3%FY 2018: -45.4%FY 2019: -30.0%FY 2020: -36.0%FY 2021: -24.0%FY 2022: -36.7%FY 2023: -8.2%FY 2024: 19.1%FY 2025: 25.0%
FY 2016 5y median -8.2% FY 2025

Growth (YoY)

Revenue 11.9%
FY 2016: 28311.5%FY 2017: 620.7%FY 2018: 79.2%FY 2019: 51.5%FY 2020: 30.3%FY 2021: 9.6%FY 2022: 6.8%FY 2023: 40.4%FY 2024: 31.8%FY 2025: 11.9%
FY 2016 FY 2025
Operating Income -54.6%
FY 2016: -65.7%FY 2017: -7.2%FY 2018: 15.4%FY 2019: 0.4%FY 2020: -16.2%FY 2021: 40.5%FY 2022: -31.2%FY 2023: 67.2%FY 2024: 414.5%FY 2025: -54.6%
FY 2016 FY 2025
EPS (diluted) 68.4%
FY 2016: -43.6%FY 2017: -0.9%FY 2018: 17.8%FY 2019: 17.5%FY 2020: -11.9%FY 2021: 41.3%FY 2022: -27.6%FY 2023: 72.4%FY 2024: 467.6%FY 2025: 68.4%
FY 2016 FY 2025
Free Cash Flow -33.1%
FY 2016: -77.4%FY 2017: 0.6%FY 2018: 22.4%FY 2019: 10.2%FY 2020: 5.6%FY 2021: 11.8%FY 2022: 10.1%FY 2023: 79.5%FY 2024: 773.3%FY 2025: -33.1%
FY 2016 FY 2025

Financial Health

Current Ratio 3.8×
FY 2016: 12.9×FY 2017: 7.6×FY 2018: 8.8×FY 2019: 10.2×FY 2020: 6.8×FY 2021: 6.4×FY 2022: 4.0×FY 2023: 2.4×FY 2024: 2.4×FY 2025: 3.8×
FY 2016 5y median 3.8× FY 2025
Quick Ratio 3.7×
FY 2016: 12.8×FY 2017: 7.5×FY 2018: 8.8×FY 2019: 10.1×FY 2020: 6.7×FY 2021: 6.3×FY 2022: 4.0×FY 2023: 2.3×FY 2024: 2.3×FY 2025: 3.7×
FY 2016 5y median 3.7× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.2×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.0×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA -0.8×
FY 2016: 0.6×FY 2017: 0.2×FY 2018: 0.6×FY 2019: 0.7×FY 2020: 1.0×FY 2021: 0.5×FY 2022: 0.2×FY 2023: 2.9×FY 2024: -2.7×FY 2025: -0.8×
FY 2016 5y median 0.2× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31